Boston Scientific Looks To Endosurgery Division For Future Growth Drivers
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will leverage its position as the number-one seller of endoscopy devices when it rolls out its Endovations system into the estimated $1.5 bil. endoscope market in Q2 2006
You may also be interested in...
J&J/Cordis Acquisition Ensures Place In Vascular Closure Arena
Cordis expects to initiate clinical trials in early 2007 for a bioabsorbable femoral artery closure device acquired through its purchase of Ensure Medical, announced July 13
J&J/Cordis Acquisition Ensures Place In Vascular Closure Arena
Cordis expects to initiate clinical trials in early 2007 for a bioabsorbable femoral artery closure device acquired through its purchase of Ensure Medical, announced July 13
Gyrus’ Purchase Of ACMI Will Boost UK Firm’s Presence In Endoscopy Space
Gyrus Group's upcoming acquisition of urology endoscope manufacturer ACMI will strengthen its presence in the rapidly growing $1.1 bil. endoscopy market, according to the London firm